Disclosure and Transfer Sample Clauses

Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. CRO/Pfizer is aware of the necessity to protect Personal Data in the context of contractual clauses and undertakes to ensure such protection. The Institution will ensure that all necessary consents are in place to comply with the provisions of this Section 6 with respect to any affected employees or contractors of Institution. 6.4
Sample 1See All (5)
AutoNDA by SimpleDocs
Disclosure and Transfer. Ferring shall share with I-MAB or any of its designees, as reasonably requested by I-MAB, the Regulatory Documentation in Ferrings’s control with respect to the Licensed Compound and the Licensed Product within sixty (60) days after the Effective Date.
Sample 1Sample 2
Disclosure and Transfer. OF Marina KNOW-HOW AND COOPERATION
Sample 1Sample 2
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. The Institution will ensure that all necessary consents, according to templates made available by the CRO and agreed with Pfizer with respect to Pfizer’s uses, are in place to carry out the data disclosures set forth under the provisions of this Section 6 with respect to any affected employees or contractors of Institution.
Sample 1
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory 6.4 Sdělování a přenos informací. Některé Osobní údaje, jimiž se zabývá článek 6 této Smlouvy, mohou být sděleny nebo předány jiným členům CRO nebo skupiny společností Pfizer, zástupcům a dodavatelům pracujícím jménem CRO nebo authorities across the world. The skupiny Pfizer a zahraničním Institution will ensure that all kontrolním úřadům. Zdravotnické necessary consents according to zařízení zajistí získání veškerých templates made available by the nezbytných souhlasů podle vzorů CRO and agreed with Pfizer with dostupných CRO a odsouhlasených respect to Pfizer’s uses, are in place společností Pfizer s ohledem na to carry out the data disclosures set použití společnosti Pfizer, jsou out under the provisions of this zavedeny k provedení zveřejnění Section 6 with respect to any údajů, aby bylo vyhověno affected employees and contractors ujednáním článku 6 této Smlouvy of Institution and shall execute the ve vztahu ke všem dotčeným EU standard contractual clauses on zaměstnancům nebo dodavatelům a controller-to-controller basis that zdravotnického zařízení a bude are attached as Attachment D. vykonávat standardní smluvní Principal Investigator will ensure ustanovení EU na bázi správce- such consent for any individuals správci, jak je uvedeno v Příloze D. working under Principal Hlavní zkoušející zajistí takový Investigator’s direction and control souhlas pro všechny jednotlivce who are not employees or pracující pod vedením a kontrolou contractors of Institution. Hlavního zkoušejícího, kteří nejsou zaměstnanci nebo dodavateli zdravotnického zařízení.
Sample 1
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. The Institution will ensure that all necessary consents are in place to comply with the provisions of this Section 6 with respect to any affected employees and contractors of Institution. Principal Investigator will ensure such consent for any individuals working under Principal Investigator’s direction and control. 6.4 Sdělování a přenos informací. Některé Osobní údaje, jimiž se zabývá článek 6 této Smlouvy, mohou být sděleny nebo předány jiným členům CRO nebo skupiny společností Pfizer, zástupcům a dodavatelům pracujícím jménem CRO nebo skupiny Pfizer a zahraničním kontrolním úřadům. Instituce zajistí získání veškerých nezbytných souhlasů, aby bylo vyhověno ujednáním článku 6 této Smlouvy ve vztahu ke všem dotčeným zaměstnancům nebo dodavatelům Instituce. Hlavní zkoušející zajistí takový souhlas pro všechny jednotlivce xxxxxxxxx xxx xxxxxxx x xxxxxxxxx Xxxxxxxx xxxxxxxxxxxx.
Sample 1
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities
Sample 1
AutoNDA by SimpleDocs
Disclosure and Transfer. FBFC shall promptly upon the written request of ORTHOVITA supply and transfer to ORTHOVITA technical documentation and KNOW-HOW in the following sequence : - At any time within a one year period from the EFFECTIVE DATE, supply of the technical documentation relating to the KNOW-HOW and implementation of the PROCESS by ORTHOVITA. - At any time within a two year period from the EFFECTIVE DATE, sequential delivery of results or medical protocols on human and animal implantations performed under contract with the K.U. LEUVEN either at the K.U. LEUVEN or in other medical centers under its scientific supervision. - Subject to the performance by ORTHOVITA of its payment obligations as provided for in Articles 4 and 5, assignment of all FBFC's property rights on the patents described in appendix 2.
Sample 1
Disclosure and Transfer. Some of the Personal Data discussed in this Section 6 may be disclosed or transferred to other members of the CRO or Pfizer group of companies, to representatives and contractors working on behalf of the CRO or Pfizer group, and to regulatory authorities across the world. The Institution will help ensure that all necessary consents are in place to comply with the provisions of this Section 6 with respect to any affected study personnel and shall execute the EU standard contractual clauses on a controller-to-controller basis that are attached as Attachment L. 6.4 Sdělování a přenos. Některé osobní údaje, jimiž se zabývá tento článek 6, mohou být sděleny nebo předány jiným členům CRO nebo skupiny společností Pfizer, zástupcům a dodavatelům pracujícím jménem CRO nebo skupiny Pfizer a kontrolním úřadům po celém světě. Zdravotnické zařízení pomůže zajistit získání veškerých nezbytných souhlasů, aby bylo vyhověno ujednáním tohoto článku 6 ve vztahu ke všem dotčeným pracovníkům klinického hodnocení a bude plnit standardní smluvní doložky EU na bázi správce-správci, která je uvedena jako příloha L.
Sample 1

Related to Disclosure and Transfer

  • Disclosure and Use 20.2.1 Each Receiving Party agrees that, from and after the Effective Date:

  • Disclosure and Use Restrictions The Executive agrees and covenants: (i) to treat all Confidential Information as strictly confidential; (ii) to not use Confidential Information except for the benefit of the Company; (iii) not to directly or indirectly disclose, publish, communicate, or make available Confidential Information, or allow it to be disclosed, published, communicated, or made available, in whole or part, to any entity or person whatsoever (including other employees of the Company) not having a need to know and authority to know and use the Confidential Information in connection with the business of the Company and, in any event, not to anyone outside of the direct employ of the Company except as required in the performance of the Executive’s authorized employment duties to the Company or with the prior consent of the Board (and then, such disclosure shall be made only within the limits and to the extent of such duties or consent); and (iii) not to access or use any Confidential Information, and not to copy any documents, records, files, media, or other resources containing any Confidential Information, or remove any such documents, records, files, media, or other resources from the premises or control of the Company, except as required in the performance of the Executive’s authorized employment duties to the Company or with the prior consent of the Board (and then, such disclosure shall be made only within the limits and to the extent of such duties or consent). Nothing herein shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order. The Executive shall promptly provide written notice of any such order to the Board.

  • Nondisclosure and Nonuse Unless authorized or instructed in advance in writing by Corporation, or required by law (as determined by licensed legal counsel), Executive will not, except as required in the course of Corporation’s business, during or after his employment, disclose to others or use any Confidential Information, unless and until, and then only to the extent that, such items become available to the public through no fault of Executive.

  • Disclosure and Assignment As of the Effective Date, Executive hereby transfers and assigns to the Company (or its designee) all right, title, and interest of Executive in and to every idea, concept, invention, and improvement (whether patented, patentable or not) conceived or reduced to practice by Executive whether solely or in collaboration with others while he is employed by the Company, and all copyrighted or copyrightable matter created by Executive whether solely or in collaboration with others while he is employed by the Company that relates to the Company’s business (collectively, “Creations”). Executive shall communicate promptly and disclose to the Company, in such form as the Company may request, all information, details, and data pertaining to each Creation. Every copyrightable Creation, regardless of whether copyright protection is sought or preserved by the Company, shall be a “work made for hire” as defined in 17 U.S.C. § 101, and the Company shall own all rights in and to such matter throughout the world, without the payment of any royalty or other consideration to Executive or anyone claiming through Executive.

  • Non-Disclosure and Non-Use The Executive shall not, during the Term and at all times thereafter, without the written authorization of the Chief Executive Officer (“CEO”) of the Company or such other executive governing body as may exist in lieu of the CEO, (hereinafter referred to as the “Executive Approval”), use (except for the benefit of the Company) any Confidential and Trade Secret Information relating to the Company. The Executive shall hold in strictest confidence and shall not, without the Executive Approval, disclose to anyone, other than directors, officers, employees and counsel of the Company in furtherance of the business of the Company, any Confidential and Trade Secret Information relating to the Company. For purposes of this Agreement, “Confidential and Trade Secret Information” includes: the general or specific nature of any concept in development, the business plan or development schedule of any concept, vendor, merchant or customer lists or other processes, know-how, designs, formulas, methods, software, improvements, technology, new products, marketing and selling plans, business plans, development schedules, budgets and unpublished financial statements, licenses, prices and costs, suppliers, and information regarding the skills, compensation or duties of employees, independent contractors or consultants of the Company and any other information about the Company that is proprietary or confidential. Notwithstanding the foregoing, nothing herein shall prevent the Executive from disclosing Confidential and Trade Secret Information to the extent required by law or by any court or regulatory authority having actual or apparent authority to require such disclosure or in connection with any litigation or arbitration involving this Agreement. The restrictions set forth in this Section 6(b) shall not apply to information that is or becomes generally available to the public or known within the Company’s trade or industry (other than as a result of its wrongful disclosure by the Executive), or information received on a non-confidential basis from sources other than the Company who are not in violation of a confidentiality agreement with the Company. The Executive further represents and agrees that, during the Term and at all times thereafter, the Executive is obligated to comply with the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding trading shares and/or exercising options related to the Company's stock. The Executive acknowledges that the Company has not provided opinions or legal advice regarding the Executive’s obligations in this respect and that it is the Executive's responsibility to seek independent legal advice with respect to any stock or option transaction.

  • Non-Disclosure and Confidentiality 9.1. All Personal Data received by the Processor from the Controller and/or compiled by the Processor within the framework of this Data Processing Agreement is subject to a duty of confidentiality vis-à-vis third parties.

  • Disclosure and Assignment of Inventions The Executive understands that the Company engages in research and development and other activities in connection with its business and that, as an essential part of the Employment, the Executive is expected to make new contributions to and create inventions of value for the Company. From and after the Effective Date, the Executive shall disclose in confidence to the Company all inventions, improvements, designs, original works of authorship, formulas, processes, compositions of matter, computer software programs, databases, mask works and trade secrets (collectively, the “Inventions”), which the Executive may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of the Executive’s Employment at the Company. The Executive acknowledges that copyrightable works prepared by the Executive within the scope of and during the period of the Executive’s Employment with the Company are “works for hire” and that the Company will be considered the author thereof. The Executive agrees that all the Inventions shall be the sole and exclusive property of the Company and the Executive hereby assign all his/her right, title and interest in and to any and all of the Inventions to the Company or its successor in interest without further consideration.

  • LICENSURE AND CERTIFICATION 25.1 The Employer will continue its current practices related to licensure and certification.

  • Non-Disclosure and Non-Use of Confidential Information The Employee agrees not to disclose, use, copy or duplicate or otherwise permit the use, disclosure, copying or duplication of any Confidential Information (other than in connection with authorized activities conducted in the course of the Employee’s employment at the Company for the benefit of the Company) during the period of including during his/her employment with the Company or at any time thereafter. The Employee agrees to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.

  • Restriction on Disclosure and Use of Confidential Information Participant agrees that Participant shall not, directly or indirectly, use any Confidential Information on Participant’s own behalf or on behalf of any Person other than Company, or reveal, divulge, or disclose any Confidential Information to any Person not expressly authorized by the Company to receive such Confidential Information. This obligation shall remain in effect for as long as the information or materials in question retain their status as Confidential Information. Participant further agrees that he/she shall fully cooperate with the Company in maintaining the Confidential Information to the extent permitted by law. The parties acknowledge and agree that this Agreement is not intended to, and does not, alter either the Company’s rights or Participant’s obligations under any state or federal statutory or common law regarding trade secrets and unfair trade practices. Anything herein to the contrary notwithstanding, Participant shall not be restricted from: (i) disclosing information that is required to be disclosed by law, court order or other valid and appropriate legal process; provided, however, that in the event such disclosure is required by law, Participant shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order prior to any such required disclosure by Participant; and (ii) reporting possible violations of federal, state, or local law or regulation to any governmental agency or entity, or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and Participant shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that Participant has made such reports or disclosures.

Time is Money Join Law Insider Premium to draft better contracts faster.